As a matter of fact, soluble forms of NKG2D ligands are present in the serum of MM patients [17, 80] and other types of malignancies; in this regard, their levels correlate with tumor stage and metastasis and with reduced expression of NKG2D on NK cells and other cytotoxic lymphocytes [81, 82]. Here, KLRK1 is linked to neoplasm.